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Abstract
The interaction between any two biological molecules must compete with their interaction with 
water molecules. This makes water the most important molecule in medicine, as it controls the 
interactions of every therapeutic with its target. A small molecule binding to a protein is able to 
recognize a unique binding site on a protein by displacing bound water molecules from specific 
hydration sites. Quantifying the interactions of these water molecules allows us to estimate the  
potential of the protein to bind a small molecule. This is referred to as ligandability. In the study,  
we describe a method to predict ligandability by performing a search of all possible combinations of 
hydration sites on protein surfaces. We predict ligandability as the summed binding free energy for 
each of the constituent hydration sites, computed using inhomogeneous fluid solvation theory. We 
compared the predicted ligandability with the maximum observed binding affinity for 20 proteins 
in the human bromodomain family. Based on this comparison, it was determined that effective 
inhibitors have been developed for the majority of bromodomains, in the range from 10 to 100 nM. 
However, we predict that more potent inhibitors can be developed for the bromodomains BPTF and 
BRD7 with relative ease, but that further efforts to develop inhibitors for ATAD2 will be extremely 
challenging. We have also made predictions for the 14 bromodomains with no reported small 
molecule Kd values by isothermal titration calorimetry. The calculations predict that PBRM1(1) will 
be a challenging target, while others such as TAF1L(2), PBRM1(4) and TAF1(2), should be highly 
ligandable. As an outcome of this work, we assembled a database of experimental maximal Kd that 
can serve as a community resource assisting medicinal chemistry efforts focused on BRDs. Effective 
prediction of ligandability would be a very useful tool in the drug discovery process.
Keywords: hydration, proteins, ligandability, drug discovery, bromodomains, water, molecular 
recognition
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Introduction
Water molecules at protein surfaces can be weakly or 
strongly bound. Therefore, the binding of a small molecule 
to a particular region of the surface is affected by the existing 
network of hydration sites in the absence of the small mol-
ecule. Quantifying the propensity of a protein to bind a 
small molecule provides an estimate of ligandability in drug 
design. The druggability of a protein target is defined as the 
relative ease or difficulty of developing a small molecule that 
can effectively modulate the protein’s activity in vivo [1]. 
However, there are many complex pharmacodynamics and 
pharmacokinetic factors influencing the ability of a small 
molecule to be effective as a drug [2, 3]. For these reasons 
predicting druggability is an extremely difficult task [4, 5]. 
However, a good indicator of protein druggability is protein 
ligandability. The ligandability of a protein is defined as the 
relative ease or difficulty of developing a small molecule that 
can inhibit the protein in vitro [6]. Predicting ligandability 
is somewhat more straightforward and, since it is necessary 
for druggability (though not sufficient), it is of great interest 
in drug discovery. For this reason, computational prediction 
of ligandability is a useful goal. In many cases, ligandability 
is phrased as the maximal affinity of a ligand for the given 
target [7–9]. There are a number of computational methods 
to predict ligandability including MAPPOD [9], SiteMap [10], 
fpocket [11], DLID [12], DrugFEATURE [13], LIGSITE 
[14], Q-SiteFinder [15], i-SITE [16], DrugPred [17], JEDI 
[18]. All of these methods apply large-scale data analysis 
to structural, and physicochemical data that is empirically 
derived using a training sets for ligands, proteins, and pro-
tein–ligand complexes.
Methods such as FTMap take a different approach, namely 
to predict ligandability without any dependence on training 
set data [19, 20]. FTMap tests different molecular fragments 
against the entire surface of the protein for locations with the 
strongest interactions. Here we report a similar approach that 
uses water molecule instead of fragments. The basis for this 
approach is the idea that the displacement of water molecules 
from a protein surface is a key contributor to protein–ligand 
binding affinity [21–29]. A set of strongly bound waters 
yields a high desolvation penalty and makes it difficult to 
bind a ligand with high affinity. The task of predicting ligand-
ability is then the task of identifying the combination of water 
molecules on the surface of the protein that is the easiest to 
displace. Whilst quantifying the displaceability of individual 
water molecules has been reported previously using inhomo-
geneous fluid solvation theory (IFST) [23, 30–34], quantifying 
the displaceability of combinations of water molecules has not 
been reported. This is a challenging combinatorial problem 
due to the large number of hydration sites surrounding a pro-
tein. Approximation methods cannot be applied in this case 
because selectivity is based on the preference of one single 
binding site over all other possible sites, such that all pos-
sible combinations must be evaluated. Moreover, proteins are 
dynamic systems and constant changes in their structure are 
reflected in responsive changes of the solvent molecules on 
the surface.
In this work, we describe a new computational tool to 
quantify the binding free energy of combinations of water 
molecules from protein surfaces. We apply the method to the 
bromodomains (BRDs) family of proteins. BRDs represent a 
good test case due to the large number of available crystal 
structures, the limited structural flexibility, and experimental 
data on small-molecule binding. BRDs are very well structur-
ally characterized. They were identified for the first time in the 
brahma gene of Drosophila melanogaster [35] and classified 
as epigenetic readers of covalent post-translational modifica-
tions of chromatin [36, 37]. In particular, the great majority of 
BRDs are capable of selectively recognizing ε-N-acetylated 
lysine residues (Kac) in histone tails [38–40]. BRD possess 
a structurally conserved interaction module about 110 amino 
acid long characterized by a left-handed four-helix bundle 
(referred to as the BRD fold: αZ, αA, αB and αC) [41] shown 
in figure 1. The binding site for acetylated-lysine is a hydro-
phobic pocket made by helices and inter-helical αZ-αA and 
αB-αC loops (ZA and BC loops, respectively). Within the 
binding pocket lies a highly-conserved asparagine residue at 
the beginning of BC loop (at the top of the pocket) and four or 
five conserved water molecules (at the bottom of the pocket) 
that participate in recognition of Kac [22]. In the last two dec-
ades, the binding motif between BRDs and Kac histone has 
been established [42, 43] and extensively reviewed [44–46]. 
Based on this protein-protein interaction motif, many inhibi-
tors have been developed [47–50]. Knowing the structure of a 
protein is very useful in the process of drug discovery and The 
Structural Genomics Consortium reveals a new BRD structure 
almost monthly [51].
There are 61 BRDs found in the human proteome appearing 
within 41 different proteins [43] that, based on their structure, 
can be divided in eight distinctive subfamilies [52]. Inhibitors 
have been developed for each of the subfamilies, from those 
deemed druggable such as BRD4 [53, 54] to those deemed 
difficult to drug such as BAZ2B [55], including inhibitors 
with mixed BRD pharmacology [56]. However most BRDs, 
Figure 1. The bromodomain binding pocket (left) is formed from 
the conserved fold of helices αZ, αA, αB and αC as well as the 
connecting loops ZA, AB and BC. It is bounded at the base by five 
strongly-conserved water molecules and at the top by a conserved 
asparagine residue. Small molecule inhibitors such as (+)JQ1 (PDB 
ID 4FLP) bind in this pocket (right).
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excluding BRD4, have not yet been studied extensively and 
thus their biological role and potential for ligandability is not 
fully understood. Thus, we apply our method to the BRDs in 
order to predict their ligandability. Because extensive lead-
optimization campaigns have not been prosecuted against 
many of the BRDs, and in some cases no inhibitors have 
been reported, we can make prospective predictions on the 
relative ease or difficulty of developing potent small molecule 
inhibitors.
We developed a suite of programs to quantify the binding 
free-energy of combinations of hydration sites from protein 
surfaces through a combinatorial search. We process informa-
tion from molecular dynamics (MD) simulation and convert 
the locations and interaction energies of explicit water mol-
ecules into their statistical representation over time, referred 
to as hydration sites [30]. We then identify which combina-
tion of hydration sites is most weakly bound by summing the 
binding energies of hydration sites in each combination. Once 
determined, such a hot spot (the location and predicted ligan-
dability) on the surface of one protein can be compared with 
hot spots on the other proteins. In this work we present details 
of the procedure for generating individual hydration site and 
assessing combinations of hydration sites as well as com-
paring the predicted and experimentally available results for 
BRDs. We have also compiled a list of the maximal reported 
affinities for each BRD, reported as Kd values measured using 
isothermal calorimetry (ITC), and discuss the potential for 
improvement in each case as well as the potential of BRD 
family members with no reported data. We hope that this 
tool will prove useful, quite early in the drug discovery pro-
cess, in distinguishing proteins that are ligandable from those 
where developing a potent small molecule inhibitor will be 
challenging.
It is important to state that analysis of hydration sites 
around a protein only looks at part of the story for small 
molecule binding. Obviously, one must also consider direct 
interaction of a small molecule with the protein and the ligand 
in solution. In a hydrophobic pocket, solvent molecules can 
be displaced from the surface of the protein with little cost 
and the corresponding non-polar interactions formed with 
the ligand are of modest size. However, strongly bound water 
molecules near polar protein groups are much harder to dis-
place, but the corresponding polar interactions formed with 
the ligand allow much greater energetic compensation. This 
work does not consider these compensation effects, but relies 
on the relationship between surface hydration sites and ligand 
displaceability established previously [30].
Methods
We identify the location of the combination of hydration sites 
with the weakest binding affinity with the ligand-binding 
hotspot and the summed binding free energy of the hydra-
tion sites with the potential for ligandability [30]. The pro-
cedure of locating such hotspots on the surface of a protein 
is performed in two steps. Firstly, hydration sites around the 
protein are generated from MD simulation. Secondly, combi-
nations of these hydration sites are compared to identify the 
combination with the weakest total binding free energy. The 
method of generating hydration sites and calculating binding 
free energies using IFST has been reported before [30, 57–59]. 
However, the evaluation of all possible combinations of hydra-
tion is reported here for the first time. Details of both steps of 
the method are given below. In terms of computer time, the 
first stage of hydration site analysis can be completed within 
24 h on a 16 CPU machine and the second stage of assessing 
all combinations can be completed within a few minutes or a 
few days on a 4 CPU machine, depending on the number of 
hydration sites in total and the number of hydration sites per 
combination. We apply the method to the BRD family. The 
list of BRDs whose structures have been processed are given 
in tables 1 and 2.
Protein structure preparation
To begin, downloaded protein structures from the Protein 
Databank [60] were prepared for analysis. We selected only 
apo protein structures for this analysis. We did not select 
crystal structures in complex with small molecules, because 
we are interested in applying the method to potential drug tar-
gets lacking existing inhibitors. Downloaded structures were 
initially processed by Schrodinger’s Preparation Wizard [61] 
by changing seleno-methionines to methionines, adding side 
chains when they were missing, checking for orientations of 
the asparagine, glutamine and histidine residues, checked 
for protonation state of all ionizable residues and removing 
all metal, buffer and solvent molecules. Proteins were sol-
vated by SOLVATE4 and we used the TIP4P-2005 water 
model [62]. Overall neutrality of the system was preserved 
by adding chloride and sodium ions placed at least 10.0 Å 
from the protein.
Molecular dynamics simulations
Prepared structures were then subjected to MD simulation in 
water. Simulations were performed using NAMD version 2.9 
[63]. Force field parameters were from the CHARMM27 force 
field [64, 65] with heavy-atom restraints of 1.0 kcal mol−1 Å−2  
for the protein and ions. Equilibration was performed for 1.0 
ns in an NPT ensemble at 300 K using Langevin temper ature 
control [66]. It was checked that the system was equilibrated 
by verifying that energy fluctuations were stable. MD sim-
ulations were performed using a time step of 2.0 fs, saving 
coordinates every 200 steps (400 fs), for a total run of 3.6 
ns. Throughout the equilibration and dynamics runs, electro-
static interactions were modeled with a uniform dielectric and 
a dielectric constant of 1.0. Van der Waals interactions were 
truncated at 11 Å with switching from 9 Å. The electrostatic 
model was the particle mesh Ewald method [67]. The entire 
systems, protein plus solvent, was treated using rhombic 
dodecahedral periodic boundary conditions which extended at 
least 10 Å from the protein surface.
4 SOLVATE is written by Helmut Grubmüller Theoretical Biophysics Group 
Institut für Medizinische Optik Ludwig-Maximilians-Universität München 
München Germany. Copyright © 1996–2013. All rights reserved.
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Hydration site identification
Since water molecules tend to cluster at protein surfaces and 
concentrate at distinct locations [57, 69], IFST is usefully 
applied to small subvolumes referred to as hydration sites 
[31–34, 70–74]. Hydration sites are then individual spherical 
regions with a high number density of water. Individual hydra-
tion sites are identified by clustering water molecules from 
the MD simulation. In this case, the clustering procedure was 
applied to a radius of 16 Å around the BRD binding site with a 
hydration site radius of 1.2 Å. Hydration sites were determined 
iteratively, starting with the water molecule in the region of 
highest water density. No hydration site was selected that was 
2.4 Å within of an already selected hydration site. Detailed pro-
cedures for clustering have been described previously [30, 57].
IFST calculations
Trajectories from the simulation were then analyzed using 
IFST to obtain the of hydration site free energies. IFST 
calcul ations are performed on simulation data from equilib-
rium MD trajectories and thus the chemical potential of water 
is constant throughout the solution. The free energy change 
calculated by IFST is the solvation free energy of the solute. 
An IFST calculation on the whole system volume yields the 
total solvation free energy. An IFST calculation on a hydration 
site yields the contribution of water molecules in that hydra-
tion site to the solvation free energy. In the context of IFST, 
the end states are a system of bulk water with N solvent par-
ticles and a solution with N solvent particles. Thus, the calcul-
ations can be considered to capture the perturbing effect of the 
solute on the water molecules [58, 59, 68]. The binding free 
energy of a hydration site (ΔGIFST) is defined as the difference 
in free energy between the water molecules in the presence of 
the protein and the same number of water molecules in pure 
bulk solution. Unlike alchemical free-energy calculations 
such as double decoupling, IFST calculations never consider 
a state with an artificial cavity. ΔGIFST is calculated from the 
energetic (ΔEIFST) and entropic (ΔSIFST) contributions to free 
energy:
∆ = ∆ − ∆G E T SIFST IFST IFST (1)
ΔEIFST is the contribution of water molecules in a hydration 
site to the total hydration energy and can be calculated from 
average solute–water (Esw), water–water (Eww), and bulk solu-
tion (Ebulk) energies:
∆ = + −E E E EIFST sw ww bulk (2)
ΔSIFST is the contribution of water molecules in a hydration 
site to the total hydration entropy. The entropy is based on 
a multiparticle expansion of the molecular distribution func-
tions [75, 76]. IFST is based on the two-particle approximation 
and thus the entropy expansion is truncated at the two-particle 
level [58]. We use a truncation of Wallace’s expansion for the 
entropy in the canonical ensemble [77]. ΔSIFST can then be 
calculated from solute–water (Ssw), water–water (Sww), and 
bulk solution (Sbulk) entropy terms:
∆ = + −S S S SIFST sw ww bulk (3)
It is important to note that the excess energy and the excess 
entropy of solution depend on the ensemble, but that the 
ensemble dependent terms cancel in the expression for the 
solute chemical potential. Thus, the chemical potential is 
equal for insertion at constant volume and constant pressure 
[78, 79]. We have shown previously that Sww is negligible for 
ordered water molecules surrounding a protein and thus we 
set this term to zero [80]. We exploit a k-nearest neighbours 
approach to calculate Ssw using the first nearest neighbour 
(k  =  1) in all cases [29, 72, 80]:
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( )= × | |d q q2 acos .ij klorient (7)
R is the gas constant, F is the number of frames sampled, Vi is 
the volume of the system in frame i, and γ is Euler’s constant, 
which corrects for the asymptotic bias. The nearest neighbour 
distance in translational space (dtrans) between two water mol-
ecules is the Euclidean norm between the Cartesian coordi-
nates of water molecule j in frame i and its nearest neighbour 
water molecule k in frame l. The nearest neighbour distance 
in orientational space (dorient) between two water molecules is 
the distance between the rotations required to bring the two 
orientations to the same reference orientation. The correct 
distance metric for the rotation group is twice the geodesic 
distance on the unit sphere. This quaternion representations 
of the rotations for water molecule j in frame i and its nearest 
neighbour water molecule k in frame l are denoted by qij and 
qkl. The total solute–water distance (dtotal) is estimated by 
combining the translational and orientational distances.
For an individual hydration site, ΔGIFST is a predominantly 
negative number between 0 and  −15.0 kcal mol−1 [80] and 
tends to zero with increasing distance from the protein (e.g. 
for water molecules 7–8 Å from the protein) where inter-
actions become more like those in bulk solvent. For the 
TIP4P-2005 water model ΔEbulk is  −11.57 kcal mol−1 and 
ΔSbulk is 15.5097 cal K−1 mol−1 [80]. Hydration sites free 
energies at the surface of CECR2 are shown in figure 2.
For each protein, 9000 snapshots from molecular dynamics 
runs were processed in order to obtain ΔGIFST for the hydra-
tion sites.
Generation of combinations of hydration sites
Combinations of interest are those that include hydration sites 
on the surface of the protein. Therefore, the cut off distance was 
applied at 3.6 Å from the surface of the protein (using heavy 
atom to heavy atom distance) and was extended to 4.1 Å when 
the hydration site was over a hydrophobic residue. The reason 
for the extended cut off was that hydration sites are found at 
a further distance from the protein for hydrophobic residues. 
J. Phys.: Condens. Matter 28 (2016) 344007
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Choosing combinations of hydration sites is in principle very 
simple (i.e. take combinations of hydration sites like those in 
figure 2). However, the technical implementation of generating, 
evaluating, and storing such combinations is a challenging 
problem. Small proteins like BRDs have a surface covered by 
about 2000 hydration sites (by the definition above). If one is to 
take all possible combinations of combinations of hydration sites 
then the number of combinations is in excess of 1040, which is 
not possible to process. This number can be significantly smaller 
if one only considers combinations that enclose hydration sites 
within a contiguous volume (since a single small molecule 
inhibitor must be contiguous). In order to avoid generating all 
possible combinations and then checking if each combination of 
hydration sites can be enclosed by a contiguous volume, 
a different approach was taken. Prior to generation of combina-
tions, every hydration site was evaluated for the number of its 
neighboring hydration sites. The cut off distance for two hydra-
tion sites to be considered neighbors was taken to be 3.38 Å. 
This distance is a reflection of the hydration site being a statis-
tical representation of water molecules. In figure 3 it is shown 
that this distance is the cut off for O–O distance in the first sol-
vation shell for TIP4P-2005 water model and that at this dis-
tance two hydration sites cannot be considered neighbors since 
the third one can be placed in-between them (which happens 
because hydration sites are never closer than 2.4 Å from each 
other). The consequence of this algorithm was that the resulting 
combinations were constituted of hydration sites that each had 
at least one neighbor (which guaranteed that a combination 
constituted a contiguous volume). For BRDs, the total number 
of such combinations did not exceed 1014. The number is still 
large yet cannot be smaller because in the search for the hot spot 
it is important not to miss a single combination. The reason for 
such exhaustiveness is to mimic proteins’ ability to have only 
one hot spot for the substrate among all possible spots on its 
surface. The method must then identify this site.
One can perform the search for combinations containing 
any number of hydration sites. Combinations of 4–6 hydration 
sites would be more appropriate for screening of fragments, 
while combinations of 30–40 hydration sites would correspond 
to small peptides. BRDs were first investigated using combina-
tions from 4 to 20 hydration sites. To identify an appropriate 
number of hydration sites for binding of a drug-like molecule, 
we calculated the volumes of hydration site combinations 
of increasing size and compared them with the volume of a 
molecule of molecular weight 500 au (figure 4). The linear 
correlation between the molecular weight and the volume of a 
Figure 2. Values of ΔGIFST in kcal mol−1 for hydration sites above the surface of the binding site of CECR2 (PDB ID 3NXB).
Figure 3. The distance cutoff between two neighboring hydration 
sites is 3.38 Å. Two hydration sites cannot be considered neighbors 
if there is the third hydration site between them.
J. Phys.: Condens. Matter 28 (2016) 344007
S Vukovic et al
6
drug (R2  =  0.85) yielded an average volume of 1414 A3 for a 
molecule of molecular weight 500 au. The number of hydra-
tion sites per combination that resulted in the volume closest to 
that size was for a combination with 18 hydration sites. Thus, 
we use combinations of 18 hydration sites for the final anal-
ysis reported here, since we estimate that this is the number of 
water molecules that a molecule of molecular weight 500 au 
would displace on average. It is interesting to note that a linear 
correlation between molecular weight and surface accessible 
solvent area has been reported previously [9].
The binding free energy of every combination (ΔGsum) 
was calculated as the sum of free energies for the 18 con-
stituent hydration sites. ΔGsum for a set of N hydration sites 
is the contrib ution of water molecules in these N hydration 
site to the hydration free energy of the protein. The binding 
free energy of the optimal combination (ΔGopt) is then the 
maximal value of ΔGsum amongst all combinations.
( )∑∆ = ∆
=
G G n
n
sum
1
18
IFST (8)
( )∆ = ∆G Gmaxopt sum (9)
Results
For each of 34 BRDs whose structures we studied (165 pro-
tein chains), we enumerated all possible combinations of 18 
contiguous hydration sites. In each case, the combination with 
the weakest binding energy is referred to as the hot spot. Thus, 
every protein has a hot spot, but the question is how ligandable 
Figure 4. A plot of the molecular weight against the volume enclosed by the solvent accessible surface area for 250 000 structures from 
the BindingDB [81]. Molecules are shown as black dots. An approximation of the distribution of volumes available to combinations of 
hydration sites of a given size is shown in blue (for 17, 18 and 19 hydration sites).
Figure 5. The predicted hot spot (green surface enclosing a combination of 18 hydration sites) for CECR2 from PDB ID 3NXB (left) and 
superimposed hot spots (blue; 18 hydration sites per combination) for all 165 chains from 34 BRD structures (right).
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is it. As an illustration, the hot spot for the BRD of CECR2 
is shown in figure  5 (green surface in the left-hand panel). 
Importantly, a correspondence between the locations of the 
predicted hot spots (blue spheres in the right-hand panel of 
figure 5), and the actual Kac binding sites (shown in figure 1) 
was observed for all 165 structures. This observation provides 
a basic qualitative validation of the approach.
We calculated ΔGopt for each of the BRDs and compared 
this with the maximum reported pKd value obtained by ITC 
[48, 82]. This data is summarized in table 1.
A graphical representation of the data can be seen in figure 6.
The majority of BRDs are predicted to have similar ligan-
dability and correspondingly most BRDs have experimental 
Kd values in the range of 10–100 nM. However, BPTF and 
Figure 6. Comparison between predicted ligandability calculated as ΔGopt (kcal mol−1) for combinations of size N  =  18 (circles) and the 
maximum observed pKd values measured by ITC (squares).
Table 1. The values of ΔGopt for combinations of 18 hydration sites and the best values for Kd measured by ITC.
BRD
ΔGopt (N  =  18)  
(kcal mol−1) Max pKd Max Kd (ITC) (nM) Ligand MW Kd ref.
ATAD2 −38.05 5.82 1500 350.40 [83]
BRPF1 −28.06 7.89 13 380.45 [84]
BRD4(1) −26.83 7.59 26 423.17 [85]
TIF1α −26.35 7.51 31 643.00 [86]
BRD3(1) −24.91 7.72 19 423.17 [85]
BRD1 −24.87 6.97 108 383.42 [87]
EP300 −24.53 7.42 38 508.20 [88]
BAZ2B −24.22 6.87 136 371.00 [89]
CREBBP −24.16 7.68 21 508.20 [88]
BRD4(2) −23.93 7.60 25 414.50 [90]
BRD3(2) −23.77 7.72 19 423.17 [85]
SMARCA4 −22.94 7.05 89 321.40 [91]
BAZ2A −22.78 6.96 109 357.42 [92]
BRD2(1) −22.44 7.34 46 423.17 [85]
PBRM1(5) −21.66 7.32 48 321.40 [91]
BRD2(2) −21.53 7.28 52 423.17 [85]
BPTF −21.50 5.55 2800 187.00 [93]
CECR2 −19.63 7.10 80 495.70 [94]
BRD9 −19.07 7.85 14 353.40 [95]
BRD7 −16.25 6.62 239 353.40 [95]
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BRD7 (green circles and squares) are different, having exper-
imental Kd values greater than 100 nM. Based on the calcu-
lated ΔGopt, the prediction is that more potent inhibitors could 
be developed for these BRDs without significant difficulty. 
In particular, BRD7 is predicted to be a highly ligandable target. 
Conversely, ATAD2 (red circle and square) is predicted to have 
a relatively low ligandability and the prediction is that signifi-
cant effort will be required to develop inhibitors approaching 
10 nM. As a product of this work, we offer a dataset of maximal 
pKd values, hoping it will serve as a community resource in 
drug discovery efforts focused on BRDs (www.tcm.phy.cam.
ac.uk/~sv375/BRDs/table/Kd_for_BRDs.html). We also con-
sidered 14 BRDs that have protein structures deposited in the 
PDB but do not have reported Kd values from ITC data. This 
data is summarized in table 2.
A graphical representation of the data can be seen in 
figure 7.
The trend observed for BRDs that do have reported Kd 
values from ITC data (figure 7 dotted line) suggests that 
identifying inhibitors with Kd in the range of 10–100 nM 
will not be a significant challenge for most other BRDs. 
However, four of these BRDs are notably different. 
PBRM1(1) is predicted to be a relatively difficult target 
(figure 7 red region), whereas TAF1L(2), PBRM1(4), and 
TAF1(2) are predicted to be a relatively ligandable targets 
(figure 7 green region). In addition to predicting ligand-
ability, we also considered the five ‘conserved’ water mol-
ecules at the bottom of the Kac binding pocket (figure 1). 
Our analysis placed hydration sites that reproduced the 
positions of these conserved water molecules for each 
BRD. The ΔGIFST values are also strongly negative, sug-
gesting that they are tightly bound. An example is shown 
for CECR2 in figure 8. The search for hot spots tends not to 
favor selection of these hydration sites.
Discussion
The primary technical challenge in this work is the enu-
meration of the trillions of viable combinations of hydration 
sites to identify the most weakly bound. This is illustrated 
for CECR2 in figure 9. The most weakly bound combination 
(shown in green) is located in the binding site, while the most 
strongly bound (red) is outside the binding site. This is the 
case for all 165 BRDs structures tested and is an encouraging 
result.
It is also important to discuss the assumptions, advantages, 
and limitations of the method. We chose combinations of 18 
hydration sites because the volume of such combinations 
corresponds to a volume of a drug with molecular weight of 
500 (figure 4). However, we studied whether the number of 
hydration sites influences the predicted ligandability. Trends 
observed with other number of hydration sites have also been 
computed and are presented in figure 10.
We observe that, in general, trends in relative ligandability 
(values of ΔGopt) are almost unchanged as the size of the 
combination changes. We observe that hot spots tend to be 
built around a small group of hydration sites that are very 
Figure 7. Predictions for ligandability of BRDs with no Kd values 
measured by ITC (orange circles) and the correspondence for BRDs 
whose Kd values are known (dotted line).
Figure 8. The crystal structure for CECR2 (PDB ID 3NXB), 
showing five crystallographic water molecules (dark blue) 
overlapping with predicted hydration sites (light blue). Hydration 
sites are labeled by their ΔGIFST values.
Table 2. The best values for ΔGopt of combinations of 18 hydration 
sites for BRDs whose values for Kd measured by ITC were not 
reported.
BRD
ΔGopt (N  =  18) 
(kcal mol−1) BRD
ΔGopt (N  =  18) 
(kcal mol−1)
PBRM1(1) −33.66 PBRM1(2) −23.65
PHIP(2) −26.93 TAF1(1) −23.40
ATAD2B −26.49 PBRM1(3) −23.29
ASH1L −26.17 KAT2B −22.50
KAT2A −24.73 TAF1L(2) −21.10
SP100 −24.57 PBRM1(4) −19.87
SMARCA2 −24.56 TAF1(2) −19.60
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weakly bound. For example, ATAD2 always has the lowest 
and BRD7 always has the highest ΔGopt value. However 
the relative ordering does change for smaller combinations 
(N  <  10). The interpretation of this observation is that suc-
cess in fragment screening might not always correspond to 
ligandability for a 500 MW inhibitor. The method described 
here can detect such scenarios and inform decision making 
in fragment-based drug design. It can also inform decision 
making in the hit-to-lead and lead-optimization stages of drug 
design. Even if a protein is ligandable and worth pursuing as 
a therapeutic target, major challenges remain in identifying 
an inhibitor in vitro and then optimizing it for use in vivo. An 
additional advantage of the method described here is that the 
results present a template for molecular design, suggesting 
the position, shape and characteristics of the eventual inhib-
itor. This information embedded in the results of the method 
is very useful in approaching the first of these challenges. An 
example is shown for BRDT in figure 11, with an inhibitor 
overlaying the most weakly bound combination of hydration 
sites. The position of the hot spot can also be used to predict 
when allosteric inhibition might be effective, while the 3D 
shape of the hot spot can be used to deduce vector poses for 
de novo drug design.
Whilst the BRDs are adequate for testing a proof of con-
cept, the applicability of the method to more diverse struc-
tures of protein families is yet to be established. BRDs are 
relatively new therapeutic target and most of those tested did 
not undergo systematic lead optimization campaigns. Thus, 
the currently available maximum Kd values are not reflective 
of the true potential. Testing this method against the well-
studied set of protein targets [9] would therefore be a logical 
progression, and is the subject of our current work. It will 
also be important to study the compensating effect of ligand-
protein interactions noted above, as this was not included in 
the cur rent analysis. In addition, it would be interesting to 
quantitatively assess the two-particle approximation used in 
IFST, to develop more accurate models. However, these are 
useful goals, because knowing the potential of a protein to 
be ligandable helps focus drug discovery efforts on targets 
that can be inhibited effectively thus saving time, effort and 
money.
Conclusion
We have presented a new method capable of generating 
and evaluating all possible combinations of hydration sites 
on the surface of a protein. Based on the identification and 
quantification of the most weakly bound combination of 
hydration sites, we predicted the ligandability of a set of 
BRDs. The majority of BRDs are predicted to have similar 
ligandability. This is in line with the maximal observed Kd 
values determined by ITC for BRDs, which are mostly in 
the 10–100 nM range. The best target for binding a small 
Figure 9. Combinations of hydration sites on CECR2 (PDB ID 
3NXB) with the lowest (green), intermediate (yellow) and highest 
(red) ΔGopt values. The most weakly bound combination (the hot 
spot) is in the Kac binding site.
Figure 10. ΔGopt for BRDs as the number of hydration sites 
changes (number of hydration sites N  =  4, 9, 14, 18).
Figure 11. Volume overlap for the predicted hot spot (purple) and 
the (+)-JQ1 ligand in BRDT (PDB ID 4FLP).
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molecule was predicted to be BRD9 and the worst ATAD2. 
This is in good agreement with the maximal observed Kd 
values determined by ITC for BRD9 (14 nM) and ATAD2 
(1500 nM). Based on the maximal observed Kd values, it 
was concluded that the majority of BRDs have good inhibi-
tors already developed. There are two notable cases where 
the maximal observed Kd values are lower than might be 
expected based on their predicted ligandability. Thus we 
predict that inhibitors for BPTF and BRD7 in the 10–
100 nM range will be developed without significant diffi-
culty. We also predicted the ligandability of the 14 BRDs 
with protein structures available in the PDB but with no Kd 
values determined by ITC. As with the majority of other 
BRDs, we expect that it will not be particularly challenging 
to develop inhibitors in the 10–100 nM range. However, we 
predict that significant effort will be required to develop 
inhibitors of PBRM1(1). Conversely, TAF1L(2), PBRM1(4) 
and TAF1(2) are expected to be highly ligandable targets. 
As a final result, we have assembled an experimental dataset 
of maximal binding affinities for the BRDs, which we hope 
will serve as a community resource to assist in medicinal 
chemistry efforts against this target family (www.tcm.phy.
cam.ac.uk/~sv375/BRDs/table/Kd_for_BRDs.html).
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